Liquidités Changement Date
AstraZeneca USD 7.56B 1.85B 2026-03
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 702M 99M 2026-03
Hikma Pharmaceutical USD 236M 48M 2025-06
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Qiagen NV USD 646.29M 192.72M 2026-03
UCB EUR 1.57B 1.14B 2024-12